Bill117th CongressFiled Jul 5, 2022Health
H.R. 8289
Banning Misleading Drug Ads Act of 2022
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Jul 5, 2022)
Banning Misleading Drug Ads Act of 2022
This bill finalizes a 2010 proposed rule from the Food and Drug Administration (FDA) regarding television and radio prescription drug advertisements if the FDA does not otherwise issue a final rule within 180 days of the bill's enactment. (The proposed rule specifies standards for major statements about a drug's side effects in television and radio advertisements.)
What just happenedJul 5, 2022
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Spanberger, Abigail Davis [D-VA-7](D-VA)Sponsor
5 cosponsors5 D
5cosponsors1committees3actions
- Introduced in HouseJul 5, 2022
- Jul 5, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jul 5, 2022IntroReferralIntro-H
Introduced in House
- Jul 5, 2022IntroReferral1000
Introduced in House